Dr. Douglas Mitchell is a former research scientist, successful businessman, and philanthropist. He is one of a very few living contemporary pioneers in the development of Sonodynamic Photodynamic Therapy, an innovative therapy for metastatic cancer. He has worked in this field since 2002 and operated one of the first clinics in the world to bring this effective and safe therapy to cancer patients.
Prior to his innovative work in cancer treatment, Dr. Mitchell worked for 15 years for the New York State Department of Health as a Research Scientist in the fields of chemistry, environmental health and medicine. During much of this time, he was Director of a Clinical Chemistry Laboratory.
In 1986, Dr. Mitchell changed career direction and founded CCA Capital Management, an investment company that used mathematical models to assist with investment decisions. He is board member of the Melba Foundation, a charitable trust that promotes Australia's classical musicians and artists on the international and national markets. Dr. Mitchell also held the Office of Chancellor of Swinburne University of Technology from 2002 to 2005 and was recently awarded an honorary doctorate from Swinburne University in recognition of his leadership and service provided towards education and the broader community.
Dr. Douglas Mitchell graduated from the University of Melbourne with a Bachelor of Science and subsequently with a Master of Science and then Doctor of Philosophy from the University of London. He has been a guest lecturer on health topics at Redemption Christian Academy. He has spoken on the topics of his program's treatments along with other health options available today such as EECP--a non-invasive treatment for heart disease, autologous stem therapy for hips and knees, and simple yet highly effective treatment of widespread vitamin D deficiency. Along with his wife, Monica, Dr. Douglas Mitchell has been RCA's major benefactor. The Mitchell's professional and personal expertise has been a tremendous longstanding asset to RCA.